BillionToOne

US · BLLN #2109 by market cap Listed 2025

95.75 -4.19 -4.19%

Live - 5344 symbols - heartbeat 245s ago · 2026-10-08 04:34

Pre-market 96.00 +0.26%

After-hours 95.75 0.00%

Market cap: 4.52B
P/E (TTM): 135.05
P/B: 8.42
EPS: 0.06
Div yield: 0.00%
52W pos: 38%

Reader sentiment Are you bullish or bearish on BLLN?

Anonymous reader poll. Unscientific, not investment advice.

About BillionToOne

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company’s patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. BillionToOne was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.

Founded: 2016
CEO: Dr. Oguzhan Atay, PhD
Employees: 713
Headquarters: Menlo Park, California, United States of America
Fiscal year end: 12-31
Website: billiontoone.com

Company profile

Exchange: US
Symbol: BLLN
Market-cap rank: #2109
Listing date: 2025-11-06
Market cap: 4.52B
Float cap: 2.76B
Shares out: 47.19M
Float shares: 28.82M

Sectors & themes

Diagnostics & Research IPOs Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 04:34:48 · For reference only, not investment advice and not tailored to your situation.